Methanol → 4-(2-tert-butyl-1-methyl-1H-imidazol-4-yl)-1H-pyrrolo[2,3-b]pyridine, trifluoroacetate salt

HRID 1501385Notes

Reaction equation

HRID 1501385 reaction equation
[C:1]([C:5]1[N:6]([CH3:27])[CH:7]=[C:8]([C:10]2[CH:15]=[CH:14][N:13]=[C:12]3[N:16](OCC[Si](C)(C)C)[C:17](C)=[CH:18][C:11]=23)[N:9]=1)([CH3:4])([CH3:3])[CH3:2].[C:28]([OH:34])([C:30]([F:33])([F:32])[F:31])=[O:29].CO.[NH4+].[OH-]>>[F:31][C:30]([F:33])([F:32])[C:28]([OH:34])=[O:29].[C:1]([C:5]1[N:6]([CH3:27])[CH:7]=[C:8]([C:10]2[CH:15]=[CH:14][N:13]=[C:12]3[NH:16][CH:17]=[CH:18][C:11]=23)[N:9]=1)([CH3:4])([CH3:2])[CH3:3]

Participants

5

Procedure

A solution of 4-(2-tert-butyl-1-methyl-1H-imidazol-4-yl)-1-[2-(trimethylsilyl)-ethoxy]-methyl-1H-pyrrolo[2,3-b]pyridine (0.010 g, 0.000026 mol) in TFA (3 mL, 0.04 mol) was stirred for 2 hours. Then the excess TFA was evaporated and the residue was stirred in methanol (3 mL, 0.07 mol) and NH4OH (1 mL) for 16 hours. The solvents were removed and the product was purified by preparative-HPLC (C18 eluting with a gradient of ACN/H2O containing 0.1% TFA) to afford 4-(2-tert-butyl-1-methyl-1H-imidazol-4-yl)-1H-pyrrolo[2,3-b]pyridine, trifluoroacetate salt (9 mg, 90%). 1H NMR (400 MHz, d6-DMSO): δ 12.24 (s, 1H), 8.38 (br s, 1H), 8.24 (s, 1H), 7.70-7.63 (m, 2H), 7.08 (br s, 1H), 2.55 (s, 3H), 1.51 (s, 9H); MS (ES): 255 (M+1).

Workup

  1. customThen the excess TFA was evaporated
  2. customThe solvents were removed
  3. customthe product was purified by preparative-HPLC (
  4. washC18 eluting with a gradient of ACN/H2O containing 0.1% TFA)

Sources & evidence

ORD record
ord-af085e57f3db405b964c886845d4d9cf
Source dataset
uspto-grants-2015_12
Patent number
US09206187B2

Reaction notes

Loading…